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Intraepithelial lymphocytes (IEL) play a major role in mucosal defense mechanisms against
intraluminal foreign antigens. To address the role luminal nutrients have on the phenotype
and function of the IEL, we administered total parenteral nutrition (TPN) to mice, with the
absence of enteral intake. We hypothesized that administration of TPN would result in
changes in the phenotype and function of the IEL. For this, we utilized a mouse model of
TPN. A significant decline in the CD4 IEL population occurred with TPN. Additionally, the
CD8,CD44 IEL subset showed a 65% decline (P  0.05), and the CD4,CD44 subset
declined by 55% with TPN (P  0.05). The CD8 population (a marker of thymic-
dependence) also declined by 92% (P  0.01) with TPN. IEL in the TPN group showed a
significantly lower degree of in vitro proliferation. In conclusion, the IEL showed significant
phenotypic changes with TPN including the loss of the thymic-derived population. Function-
ally, the IEL showed a significant decline in proliferation. Such changes demonstrate the
important role luminal nutrients have on IEL phenotype and function.
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Many patients, because of either a lack of gastroin-
testinal length or gastrointestinal dysfunction, are un-
able to take feedings via the enteral route. These
patients are confined to a prolonged course of total
parenteral nutrition (TPN). Total parenteral nutri-
tion is used in over half a million patients each year in
the United States, alone (1). Despite being an essen-
tial form of therapy, patients receiving TPN have a
significantly greater risk of developing septicemia and
wound infections compared to patients receiving en-
teral nutrition (2–4). The etiology of this increased
incidence of infections is not clear. It is believed,
however, that the intestine may be the source of the
organisms responsible for these septic episodes (5, 6).
In fact, the intestine of both experimental animals
and humans undergoes a number of changes with
TPN, including a loss of epithelial height, absorptive
capacity, and mucosal barrier function (7–10). Be-
cause of the close relation of the intraepithelial lym-
phocyte (IEL) population and intestinal epithelial
cells, we hypothesized that the composition and func-
tion of the IEL may rely on normal enteral nutrition
and would change with TPN.
Intraepithelial lymphocytes have a complex role.
They act as the initial lymphoid defense layer against
intraluminal foreign antigens, and IEL, must down-
regulate immune responses to many enteral antigens
in order to prevent an overwhelming immunologic
response (11, 12). The IEL possesses a unique phe-
Manuscript received February 5, 2001; accepted June 15, 2001.
From the Section of Pediatric Surgery, Department of Surgery
University of Michigan Medical School, and C. S. Mott Children’s
Hospital, Ann Arbor, Michigan.
Supported by NIH grant AI44076-01 and Abbott Laboratories,
Hospital Division.
Address for reprint requests: Dr. Daniel H. Teitelbaum, Section
of Pediatric Surgery, University of Michigan Hospitals, Mott
F3970, Box 0245, Ann Arbor, Michigan 48109.
Digestive Diseases and Sciences, Vol. 47, No. 5 (May 2002), pp. 1147–1157 (© 2002)
1147Digestive Diseases and Sciences, Vol. 47, No. 5 (May 2002)
0163-2116/02/0500-1147/0 © 2002 Plenum Publishing Corporation
notype of T cells (13). The IEL consists of a predom-
inant subpopulation which is CD8,CD4 (70–85%,
for mice, single positive), with smaller populations
consisting of the following phenotypic distribution:
CD8,CD4 (5–10%, double negative); CD8,CD4
(5–12%, single positive); and CD8,CD4 (4–10%,
double positive) (13–15). Another important charac-
teristic of the IEL is the large number of TCR cells;
up to 50% of IEL are TCR compared to less than
2% in peripheral blood lymphocytes of mice (16, 17).
Additionally, the derivation of the IEL has been
shown to originate from a thymic independent (18),
as well as a thymic dependent source (13, 16, 19).
Experiments using RAG2/ knockout mice, injected
with bone marrow of nude mice, led to the develop-
ment of a virtually absent peripheral T-cell popula-
tion, but an IEL population containing CD8 (ho-
modimeric chains),CD4 cells with either  or 
TCR (20). This extrathymic origin is TCR,CD8,
whereas TCR,CD8/ cells are of thymic origin
(20).
A considerable amount of work has concentrated
on the assessment of IEL function. Investigators have
stimulated the IEL under a variety of conditions
including alloantigen, plant lectins and, more re-
cently, heat shock proteins and superantigens (21–
25). Investigators have shown the IEL to proliferate
with many established mediators of lymphocyte stim-
ulation; however, it proliferates at a much lower
extent than most other lymphoid populations (18, 21).
Because of the large CD8 population, cytotoxic ac-
tivity has also been investigated. Mosley et al (26) and
Ebert (27) demonstrated the IEL to have a large
population of cytotoxic T lymphocytes that were able
to perform a redirected cytotoxic function without in
vitro activation. The actual significance of these ac-
tions has not been well defined; however, these func-
tions may be critical for the organism to protect itself
from harmful intraluminal pathogens.
During early postnatal development, the IEL rap-
idly develops in the mouse (28). Changes include an
expansion of the T-cell receptor (TCR)  and
CD4 populations (29). Although it has been previ-
ously shown that the presence of luminal bacteria
plays a critical role in IEL maturation (29, 30), it is
not clear what role luminal nutrients may have on the
phenotype or function of the IEL. An interdepen-
dence of the IEL and epithelial cells has been well
described, including the production of growth factors
and cytokines, which support both the composition of
the mucosal layer and its function (31). Therefore, the
observed changes in epithelial structure and function
with administration of TPN may reflect similar
changes in the IEL. This study examined phenotypic
and functional changes of the IEL in a mouse model
of TPN.
MATERIALS AND METHODS
Animals. The studies reported here conformed to the
guidelines for the care and use of laboratory animals estab-
lished by the University Committee on Use and Care of
Animals at the University of Michigan and protocols were
approved by that committee. Male, 2- to 4-month-old, spe-
cific-pathogen-free, C57BL/6 mice (Jackson Lab, Bar Har-
bor, Mainè, USA) were housed in metabolic cages and
maintained in temperature, humidity and light-controlled
conditions.
Operative Procedures. Mice were anesthetized with so-
dium pentobarbital (50 mg/kg body weight, intraperitone-
ally). A silicone rubber catheter (0.012 in. ID  0.025 in.
OD; Konigsberg Instruments, Inc., Pasadena, California,
USA) was inserted into the superior vena cava via the left
jugular vein. The distal end of the catheter was tunneled
subcutaneously. The catheter exited between the scapulae
and was attached to a swivel spring, which allowed the mice
freedom of movement in their individual cages (Metamount
System, Instech, Corp, Plymouth Meeting, Massachusetts,
USA). Catheterized mice were connected to an infusion
pump (AIM pain provider pump, generously donated by
Abbott Laboratories, Abbott Park, Illinois, USA) and sa-
line (dextrose 5% in 0.45NS with 20 meq KCl/liter) was
infused at an initial rate of 4 ml/day. After 24 hr, animals
were randomized into two groups. The control group re-
ceived the same intravenous physiologic saline at 7 ml/24 hr,
in addition to standard laboratory mouse chow and water
ad libitum. The TPN group received a standard TPN solu-
tion intravenously with no oral intake. The TPN solution
contained a balanced mixture of amino acids, lipids, and
dextrose in addition to electrolytes, trace elements, and
vitamins (32). Caloric delivery was based on previous mea-
surements of caloric intake of control mice and from pre-
vious investigators, so that caloric and protein delivery was
essentially the same in both groups (32). Mice were killed at
seven days using CO2.
Cell Isolation. IEL was isolated similar to that described
by Mosley and Klein (33). After small bowel resection,
mesenteric fat and Peyer’s patches were removed. The
intestine was opened and agitated to remove mucus and
fecal material. The intestine was cut into 5-mm pieces,
washed three times in an IEL extraction buffer [1 mM
EDTA, 1 mM dithiothreitol in phosphate-buffered saline
(PBS)], and incubated in the same buffer with continuous
brisk stirring at 37°C for 30 min. The supernatant was then
filtered rapidly through glass wool, placed in 40% isotonic
Percoll (diluted in the IEL extraction buffer; Pharmacia,
Piscataway, New Jersey, USA) centrifuged for 20 min at
500g at 28°C. Splenocytes, thymocytes, and inguinal and
axillary lymph nodes were isolated from the mouse prior to
the manipulation of the intestine. Cells were suspended in
PBS, filtered through nylon mesh, and for splenocytes and
lymph nodes further purified using gradient centrifugation
with Lympholyte M (Cedar Lane, Ontario, Canada) for 20
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min at 28°C at 500g. For proliferation assays, splenic B cells
were depleted using standard panning techniques (34).
Bacteriological Cultures. For qualitative analysis, the
methods used were similar to those previously described
(35). After killing the mice, and using sterile technique,
samples of tissue (N  8 per group) from the midportion of
the small bowel and cecum were excised. Each tissue sam-
ple was incubated in thioglycolate broth for 24 hr at 37°C.
Samples were then subcultured aerobically onto either
MacConkey media for isolation of gram-negative bacteria,
or colistine naladixic acid media (Becton Dickinson, Cock-
eysville, Maryland, USA) for isolation of gram-positive
bacteria. Following an additional 24-hr incubation period,
growth on each plate was recorded as either positive or
negative.
For quantitative analysis, in a separate group of mice
(N  6 per group), using sterile technique, the lumen of the
small intestine was flushed with 1 ml of PBS. The effluent
was collected and sent for semiquantitative analysis of nor-
mal flora and for selected pathogens (Great Smokies Vet
Science, Asheville, North Carolina, USA). Because the
volume of stool in control and TPN groups varied greatly,
with that in control being much greater than TPN mice (at
times TPN mice had almost unmeasurable mice amounts of
stool), it was impractical to try to determine a precise
number of bacteria per small intestine. Therefore, quanti-
fication of each organism was expressed on a graded scale
from 0 to 4, and the mean grade was expressed in both
groups. A grade of 0 was given for no growth, with progres-
sively higher grades given to larger amounts of growth
obtained after 48 hr of culturing the stool.
Flow Cytometry. Except where noted, antibodies were
obtained from PharMingen (San Diego, California, USA)
and consisted of (clone): CD4 (RM4-5), CD8 (53-6.7),
CD8 (53-5.8), CD44 (IM7), CD45RB (16A), T-cell recep-
tor  (Gibco BRL, H57), T-cell receptor  (Gibco BRL,
GL3), and Thy1 (G7). Isotype-matched, irrelevant antibod-
ies were used as negative controls. Samples of IEL and
thymocytes were also assayed for cell death with propidium
iodide as a marker of cell necrosis and cell surface expres-
sion of phosphatidylserine (Annexin V Fluos stain; Boehr-
inger Mannheim, Indianapolis, Indiana, USA), as a marker
of apoptosis. Flow cytometry was performed using standard
techniques (36) and a Becton-Dickinson FACScan (Becton-
Dickinson, Mountainview, California, USA).
Proliferation Assays. Isolated IEL and splenocytes were
counted and set to a concentration of 2  105 cells/100 l in
tissue culture medium [RPMI 1640, 2 mM glutamine, pen-
icillin and streptomycin, 2-mercaptoethanol (5  105 M)
and 10% heat-inactivated fetal calf serum (all supplied by
Gibco BRL, New York, New York, USA)]. Cells were
stimulated on anti-CD3 (derived from hybridoma 145-
2C11) coated 96-well tissue culture plates (antibody applied
at a concentration of 10 g/ml, and incubated at 4°C over-
night), and all assays were performed in triplicate. An
additional group of cells were stimulated with exogenously
supplied IL-2 (derived from rat-conditioned media) (34, 37)
along with bound anti-CD3. Samples were compared to
control wells treated with anti-dinitrophenol (clone UC8;
kindly supplied by Dr. Jeffery Bluestone, Chicago, Illinois,
USA). Samples were incubated at 37°C, with 95% O2, 5%
CO2 for 72 hr. Proliferation was assessed by the addition of
[3H]thymidine (1 Ci/well), followed by harvesting of the
cells 18 hr later and counting of radiation. Proliferation was
expressed as the mean counts per minute (cpm) of radio-
activity.
Data Analysis. Statistical analysis was carried out using
paired t tests for the flow cytometry and proliferation data,
with SPSS software (SPSS Inc., Chicago, Illinois, USA).
P  0.05 was considered significant. Unless otherwise
indicated results are expressed as the mean  SD. For
analysis of semiquantitative cultures, a Wilcoxon Signed
Ranks test was used.
RESULTS
General Description of Mice. Total amount of ad-
ministered intravenous fluid was a mean of 7.3  1.4
ml/day for the TPN group and 7.0  1.8 ml/day for
the control group (P  0.05). Mean caloric intake
for the TPN mice was 9.0  1.7 kcal/day. Body
weights were recorded before the initiation of the
study and after mice were killed. Body weights at the
beginning and end the study were 25.6  1.4 g and
24.2  1.3 g for the TPN group and 25.0  1.7 g and
24.8  1.4 g for the control group, respectively (P 
0.05, between and within groups).
Number of Isolated Cells. Cell counts isolated from
each population are shown in Table 1. No significant
differences were noted in IEL, epithelial cells, or
splenocytes between TPN and control groups. The
number of thymocytes in the TPN group was lower
than the control group; (P  0.05). It was interesting
to note that the yield in the number of IEL and
intestinal epithelial cells rose in the TPN group. Be-
cause of fairly large standard deviations, the differ-
ences did not approach significance.
Bowel Colonization and Cultures. Small intestinal
bacterial colonization results were similar for the
TPN and control groups. Specifically, gram-positive
bacteria were cultured in 11 of 13 mice in the TPN
group and 8 of 11 control mice. Gram-negative bac-
teria were identified in 10 of 13 TPN mice and 7 of 11
controls mice (p  0.05).






IEL 8.1  5.6 10.2  6.6
Intestinal epithelial cells 10.6  6.9 21.7  18.5
Splenocytes 44  1.6 41.9  3.1
Thymocytes 50.2  9.0 34.5  4.7
*Cell counts isolated from each lymphoid population in the control
and TPN groups (N  6).
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Semiquantitative small bowel cultures (N  6 in
each group) are shown in Table 2. Most bacterial
strains were similar between the study groups. Some
differences, however, were noted. It was interesting to
note that both Bifidobacterium sp. (P  0.01) and
Lactobacillus sp. (P  0.05) were isolated more
frequently and in higher amounts in the TPN group.
Enterobacter sp. were found more frequently and in
higher numbers in the control group, and this differ-
ence approached significance (P  0.1). This sug-
gests that the short-term removal of enteral nutrition
has relatively little influence on bacteria in the small
intestine and may not be the driving for behind the
observed changes in the IEL. Nevertheless, Bifidobac-
terium and Lactobacillus have been shown to influ-
ence immune responses in the intestine and may have
contributed to some of the observed changes.
Phenotypic Results. Regarding phenotypic results
in IEL subpopulations; flow cytometric analysis
showed several unique differences between the TPN
and control groups (Table 3 and Figures 1–4). Ad-
ministration of TPN was associated with a statistically
significant decrease in the number of CD4 IEL. This
was noted for both the single positive CD4,CD8
(87% decline, P  0.01) and the double positive
CD4,CD8 (80% decline, P  0.05) IEL subpopu-
lations (Figure 1). The CD4,CD8 and CD4,
CD8 populations did not appreciably change be-
tween the two groups (P  0.05). CD44 was used as
a marker of lymphocyte maturation and is manifested
by increased expression. The CD44 IEL subset de-
clined in the TPN group compared to control animals
(Figure 2). The CD8,CD44 subset in the TPN
group showed a 65% decline (P  0.05), and the
CD4,CD44 subset showed a 55% decline (P 
0.05) with TPN. Other markers of T-cell maturity
showed variable changes. The CD62L population,
which is normally not expressed in mouse small intes-
tine IEL, rose from less than 2% in the control group
to 8% in the TPN group. The CD45RB population
was relatively unchanged between the two groups.
The CD8 subpopulation (ie, CD8 het-
erodimeric; thymic-dependent subpopulation) signif-
icantly declined (P  0.01) in the TPN group (91%
decrease). The CD8 subpopulation (eg, CD8 ho-
modimeric) did not change significantly with TPN
(Figure 3). The Thy1 population (Table 3) was
TABLE 2. SEMIQUANTITATIVE, AEROBIC STOOL CULTURES FROM
SMALL BOWEL*
Organism Control group (range) TPN group (range)
Lactobacillusa 0 1.0 (0–4)
Bifidobacteriab 0.2 (0–1) 2.3 (0–4)
Enterobacter sp.a 2.0 (0–4) 0.67 (0–4)
Gamma strep 3 (1–4) 2.67 (0–4)
Klebsiella sp. 0.5 (0–3) 0.33 (0–1)
Pseudomonas sp. 0.8 (0–4) 0.17 (0–1)
Staphyloccocus sp. 0.7 (0–4) 1.3 (0–4)
Proteus mirabilis 0 0.7 (0–4)
*Results are given from mice in either the control or TPN study
groups (N  6/group). Cultures are performed on the selected,
prominent aerobic species and common pathogens. Quantifica-
tion is given as the mean amount for each group of bacterial
species with grades ranging from 0 (None identified) to 4 (max-
imal growth). Comparisons were made between control and TPN
groups by using a Wilcoxon signed ranks test.
aP  0.05, bP  0.01; remaining comparisons were not significant.






CD4,CD8 Single positive 4.7 (3.9–6.1) 0.6 (0.2–0.7)**†
CD4,CD8 Double positive 3.0 (2.5–4.3) 0.6 (0.1–1.0)*‡
CD4,CD8 Single positive 65 (58–70) 64 (37–79)
CD4,CD8 Double negative 28 (23.2–34) 35 (19.3–64)
 T-cell receptor 39 (23–33) 22 (12–31)
 T-cell receptor 62 (33–53) 70 (37–56)
CD8 Thymic-dependent 4.8 (3–6.5) 0.4 (0.1–.08)**†
CD8 Thymic-independent 64 (59–71) 52 (40–63)
CD4CD44 Mature T-cell 4.4 (1.9–5.4) 2.0 (0.4–6.6)
CD8CD44 Mature T-cell 29 (28.4–37.2) 10 (1.0–18.0)‡
Thy1CD8 Thymic dependent 23 (18–38) 10 (7–20)‡
CD4CD25 IL-2 receptor positive 0.3 (0–0.9) 0.4 (0–1.8)
CD4,CD25 IL-2 receptor negative 5.7 (4.4–6.6) 1.9 (0.9–2.5)*‡
CD8,CD25 IL-2 receptor positive 3.8 (0–7.7) 8 (1.2–14.7)
CD8,CD25 IL-2 receptor negative 58 (48.5–64.8) 59 (48.7–69.8)
*Results are expressed as the mean percent of gated cells (based on forward and side
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studied as an additional marker of thymic depen-
dence. Thy1 IEL declined with TPN from 23% of all
CD8 cells in the control group to 10% of CD8 cells
in the TPN group, although the difference was not
significant. The TCR  subpopulation of the IEL
declined from 39% to 22%; however, the difference
was not statistically significant. The  subpopulation
in the IEL was not statistically different between the
two study groups (62% vs 70%, for the control and
TPN groups, respectively; Table 3).
Regarding results in systemic lymphoid populations
the numbers of splenocytes were not significantly
different between study groups (Table 1). The pheno-
typic changes in the IEL did not appear to reflect
systemic changes. Analysis of CD4 and CD8 pop-
ulations in peripheral lymph nodes (Figure 1) and
splenocytes (not shown) showed no significant differ-
ences between TPN and control groups. Splenocytes
showed the following mean percent distribution:
CD4 70% vs 63%; CD8 30% vs 37%; CD44 70%
vs 63%; and CD8 93% vs 94%, for the TPN and
control groups, respectively.
Because of the loss of the IEL thymic-dependent
population, thymic subpopulations were also evalu-
ated. The total number of thymocytes was statistically
lower in the TPN Group (Table 1). Analysis of thy-
mocyte subpopulations showed a significant decline
(P  0.05) in the CD4,CD8 double-positive pop-
ulation (from a mean of 74% in the control group to
42% in the TPN group). Along with this was a sub-
sequent rise in CD4 (mean of 8% to 30%, control and
TPN, respectively) and CD8 (mean of 5% to 18%)
Fig 1. Distribution of CD4 and CD8 intraepithelial lymphocytes (IEL) (left column) and inguinal lymph nodes (right
column) of the same mouse for both a representative control (top row) and TPN (bottom row) mouse. Gated
populations are expressed as the percent with each phenotypic marker based on isotype matched control antibodies.
Control group received intravenous saline and ad libitum chow; TPN group received intravenous nutrition and no enteral
nutrition or water. Note the loss of CD4 cells in the TPN IEL compared to stable CD4 populations in the lymph node
of the same animal.
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single positive cells (Figure 4). It is uncertain whether
this represents a loss of the more immature thymo-
cytes or an accelerated maturation into single positive
cells.
We next addressed whether the loss of cells in the
IEL and thymus was due to an apoptotic process or
cell necrosis (Table 4). IEL showed a 79% increase in
apoptosis in the TPN group. Similarly, the thymus
showed a 40% increase. Neither of these increases,
however, were statistically significant. Other changes
between groups for both the IEL and thymus were
not statistically significant.
Proliferation Studies. Overall the IEL in TPN mice
had lower levels of proliferation compared to controls
(Figure 5). IEL proliferation with immobilized anti-
CD3 alone resulted in low levels of proliferation
compared to splenocytes from the same mouse. The
addition of IL-2 significantly (P  0.05) increased
IEL proliferation. Although the control IEL popula-
tion increased proliferation by over 28-fold (310 vs
8820 cpm, with and without IL-2, respectively), the
TPN group increased proliferation by only threefold
(384 vs 1132 cpm). For the splenocyte population,
anti-CD3 stimulated proliferation was low in the TPN
group (13,245 vs 48,819 cpm; TPN and control
groups, respectively). Splenocyte proliferation im-
proved with addition of IL-2, so that the degree of
increased proliferation was actually higher in the TPN
group (62%) compared to the control group (38%).
To examine the influence of IL-2 on the prolifera-
tive changes, CD25 expression (IL-2 receptor) was
studied (see Table 3 for percent changes). There was
a significant decline in the IEL CD4,CD25 popu-
lation with TPN, although this most likely repre-
sented an overall decline in CD4 cells. The
CD8,CD25 population doubled in the TPN group,
although the difference was not significant.
DISCUSSION
Our study demonstrated a significant change in
both the phenotypic and functional characteristics of
the IEL in mice maintained on TPN. This finding is
significant in that administration of TPN is associated
with a markedly increased risk of septicemia in both a
clinical setting and in experimental animal models (3,
38). The intestine has been implicated as the source
of this sepsis by many investigators, in that the ma-
jority of organisms isolated are of enteric origin (5,
39). It has been hypothesized that a loss of mucosal
Fig 2. Distribution of phenotypic markers for T-cell maturation. CD8 cells are shown as well as CD44 (left column), CD62L (middle
column), and CD45RB (right column) of the same mouse for both a representative control (top row) and TPN (bottom row) mouse. Note
the decline of CD44 cells in the TPN group, as well as a slight increase in the CD62L cells and little to no change in CD45RB cells.
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immune function may be the cause of this increased
risk of sepsis. In a study by Kudsk et al, changes in the
IEL during TPN administration to mice were directly
correlated with an increased risk of pulmonary infec-
tions (40). This study documented a significant de-
crease in the number of IEL associated with the
administration of TPN. In a study by Guihot, et al,
rats enterally fed parenteral nutrition (elemental
diet) also developed changes in IEL (41). Similar to
the Kudsk study, a decline in the number of CD4
and CD8 IEL was noted. However, in neither of
these studies was a detailed analysis of many of the
unique characteristics of the IEL performed. Addi-
tionally, it is difficult to know if the administration of
an enterally fed elemental diet, as performed in the
study by Guihot study, can adequately mimic the
changes that occur with TPN. In a more recent study
on the immunologic changes associated with TPN,
Ganessunker et al described the changes seen within
the lamina propria of neonatal piglets receiving TPN
(42). In their study, a threefold increase in the num-
ber of T lymphocytes (both CD4 and CD8) was
observed in those mice receiving TPN. In fact, there
was a reverse relationship between the decline in
villus height and the rise in T lymphocytes.
Intraepithelial lymphocytes are the population of
cells located between intestinal epithelial cells (13).
These lymphocytes are one of the first immunologic
populations to be exposed to luminal antigens and
pathogens and thus appear to play a role in mucosal
immune defense mechanisms. Their precise function
is complex, in that their ability to proliferate against
exogenous stimuli or alloantigens is significantly
lower than other lymphoid populations (14, 21, 23, 24,
43, 44). The IEL has a unique phenotype bearing
both CD4,CD8 double-positive and double-negative
T lymphocytes (33, 45). Another unique phenotype of
this cell population in the mouse is the large (30–
60%) percentage of TCR lymphocytes (46). Fur-
ther, the origin of the IEL has been shown to arise
from both a thymic-dependent and thymic-indepen-
dent source (20, 47, 48).
In our study, the CD4 IEL population declined by
over 80% with TPN. This loss included a decline in
the CD4,CD8 and the CD4,CD8 subpopula-
tions. The implications of this loss are difficult to
interpret. It is known that the proliferative activity of
the IEL is predominately confined to the CD4 pop-
ulation (13, 49). It is possible that the observed loss of
proliferation in our study may well be attributed to
this decline in the CD4 population.
The majority of IEL appear to have a phenotype
consistent with a mature and activated cell popula-
tion. This is reflected in the relatively large number of
CD44 cells (50–52). Our finding of a decline in the
CD44 population suggests that the IEL became less
mature with TPN. The finding of large expression of
CD45RB has been previously reported (53), and little
change was noted in CD45RB expression with TPN.
The high expression of CD45RB is somewhat in con-
flict with the expression of CD44. Although CD45RB
is conventionally used as a marker of maturation for
peripheral CD4 cells (54, 55), it may not represent
maturation in CD8 cells, particularly those in the
IEL. It was interesting to note that CD62L expression
was almost completely absent in the control group,
but rose to 8% of the CD8 cells in the TPN group.
This finding is unusual in that CD62L is typically




Cell necrosis 4.2  3.1 10.1  9.2
Apoptosis 9.9  10.6 2.1  2.1
Thymus
Cell necrosis 1.9  2.6 2.9  2.8
Apoptosis 9.3  8.7 5.6  2.4
*Results are expressed as the mean percent of population  SD, N
was a minimum of 5 per group. No differences were statistically
significant between the two groups.
Fig 3. Distribution of CD8 and CD8 IEL in a representative
control (top row) and TPN (bottom row) mouse. Note the almost
complete loss of CD8 cells in the TPN IEL.
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described in peripheral lymphoid populations and is
not found in the IEL. However, a similar rise in
CD62L expression was recently noted by Seibold et al
when IEL were isolated and cultured for several days
in vitro (50). The expression of CD62L in these cul-
tures was reversed by adding phorbol myristate ace-
tate. This suggests that removing intraluminal factors,
possibly those derived from nutrients, may remove a
source of stimulation for IEL that drives them into a
mature state. The decline in CD44 cells with TPN
may also have other functional implications. CD44
expression is needed for activated T-cell migration,
via rolling, into an inflammatory site (56). Therefore,
the decline in CD44 cells with TPN may also repre-
sent a decreased requirement for T-cell recruitment
into an intestine that is lacking a normal number of
foreign luminal antigens. Changes in the functional
characteristics of mucosal immunocytes were also
seen in a report by Ganessunker et al (42). In this
study, neonatal piglets showed an increase in MHC II
expression, possibly an indicator of intestinal inflam-
mation, when given TPN.
A number of factors are known to be responsible
for the development and maintenance of the IEL.
These include the introduction of enteric organisms
into the gastrointestinal tract. A direct correlation is
noted between the bacterial colonization of the intes-
tine and the maturation of the IEL (35). Germ-free
mice will fail to develop a normal IEL population
(57). Introduction of bacteria leads to a rapid increase
in total cell number and an expansion of the CD4
and TCR populations (29, 58). A second mecha-
nism by which the IEL matures is the introduction of
nutrients. The IEL has been shown to change signif-
icantly with the transition from breast milk to stan-
dard rodent chow (59). A number of studies have
shown that bacterial organisms can influence IEL
development (25, 29, 60). It is possible that these
changes in bacterial flora may be one of the mecha-
nisms responsible for IEL changes noted in our study.
However, it appears less likely that such TPN-
associated changes in the IEL are due to alterations
in the microbial environment of the intestine, because
colonization of the small and large bowel was not
significantly different between study groups. Semi-
quantitative cultures, however, showed some small
but interesting differences between the two groups.
Interestingly, the number of Bifidobacterium sp. and
Lactobacillus sp. increased in the TPN group, and the
number of Enterobacter sp. were higher in the control
group. This change was surprising to us because we
did not anticipate the number of “beneficial” organ-
ism such as Bifidobacterium and Lactobacillus would
increase without enteral nutrition. In fact, it has been
shown that several species of Lactobacillus can inhibit
lymphocyte proliferation, which may explain the ob-
served loss of IEL proliferation with TPN (61). Ad-
ditionally, Lactobacillus has been shown to increase
the expression of CD25 cells in the intestine (62).
Such an action may have contributed to the increase
in CD8,CD25 cells seen in our TPN mice.
The thymic-dependent and thymic-independent
portions of mouse IEL have been differentiated by
the presence of CD8 cells in the thymic-
dependent and CD8 cells in the thymic-indepen-
dent population (20). Each of these populations may
posses different functional characteristics (12, 63, 64).
One of the most intriguing results of our study was
the loss of the CD8 population with the removal
of enteral nutrition, whereas the CD8 population
(thymic-independent) did not significantly change.
The precise etiology of these changes is uncertain, but
it may have significant functional implications. This is
particularly important as the thymic-dependent por-
Fig 4. Distribution of CD4 and CD8 cells in the thymus of a
representative control (top row) and TPN (bottom row) mouse.
Note the marked decline in the number of double-positive thymo-
cytes in the TPN group and rise in the single-positive populations.
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tion of the IEL has been shown to be the predomi-
nant population contributing to the bulk of IEL pro-
liferative activity (65). The thymic-independent
population has been suggested to be a mediator of
transforming growth factor expression and may serve
to down-regulate immune responsiveness (12). Thus,
this loss of the thymic-dependent population may
help explain the observed decline in the proliferative
response of the IEL. It was interesting to note that
the Thy1 IEL population declined much less than
the CD8. Although previously thought to be a
marker of thymic derivation, more recently, it appears
that Thy-1 does not truly reflect the thymic-
dependent portion of the IEL (66). Our finding of a
loss of the thymic-dependent subpopulation is similar
to the findings of Guihot, et al. In their study, they
noted a decline in CD5 cells, a population that has
been considered to be thymic-dependent by some
investigators (67). The potential mechanisms by
which these changes in the IEL population occur with
TPN have not been determined. It is possible that
alterations within the thymus during TPN administra-
tion might be responsible for many of these observed
changes. The number of thymocytes in the TPN group
significantly declined. Additionally, the large decline
in the CD4,CD8 double positive thymocytes may well
have a role in the loss of the thymic-derived portion of
the IEL. Other factors, including failure in homing of
these lymphocytes to the bowel or a loss of these cells
once they have arrived in the epithelium, have not
been excluded. Additionally, the fact that there was
an increased incidence of septicemia in mice on TPN
(68) suggested that this may lead to thymic atrophy
via an apoptotic process. Ayala et al have shown that
such an apoptotic process may occur during episodes
of sepsis (69, 70). Our studies, however, showed that
apoptosis was seen in a relatively small percentage of
thymocytes (5.5–9%), and this percent did not signif-
icantly change with administration of TPN. A recent
study has shown that the formation of the CD8
population of the IEL requires the presence of major
histocompatibility complex proteins K-b and D-b in
H-2(b) mice (71). It is possible that the loss of enteral
nutrition may result in an alteration in MHC expres-
sion or stimulation, which could result in a loss of this
thymic-dependent population.
The marked decrease in IEL proliferation with
TPN suggests that the IEL may not be as responsive
to intraluminal pathogens during TPN administra-
tion. This may help explain why patients lacking en-
teral nutrition are at increased risk for developing
systemic septicemia. It was interesting to note that the
TPN group was less responsive to IL-2 stimulation
compared to controls, despite an increase in IL-2
receptor expression in the CD8 population. It is pos-
sible that the concomitant loss of CD4 cells, and
their known ability to proliferate greater than CD8
cells, was the predominant reason for the loss of IEL
proliferation with TPN.
To truly understand the role enteral nutrition has
on the development of the IEL, the complete removal
of all nutrients from the enteric tract is necessary. Our
current study clearly demonstrates the need for such
nutrients to maintain normal IEL phenotype and
function. Administration of TPN in a mouse model
resulted in significant alterations in the phenotypic
subpopulations of the IEL and a decline in the pro-
liferative response. Changes in the phenotypic expres-
sion appeared to reflect a loss of the thymic-
dependent population and a shift to a more immature
Fig 5. Proliferation results are shown. Proliferation is expressed as thymidine uptake into lymphocytes in counts per minute. Cells
were stimulated with either bound anti-CD3 alone or with the addition of rat conditioned media (RCM) as a source of interleukin-2.
(A) IEL; (B) splenocytes. *P  0.05 comparing proliferation before and after the addition of RCM, as well as between control and
IEL groups.
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group of cells. Such changes may explain why patients
on TPN have a higher incidence of septicemia. Po-
tential interventions to reverse these changes may be
efficacious in reducing the complications of sepsis
during administration of TPN.
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